Key result
Diffuse large B-cell lymphoma presents atypically as mesenteric mass with superior mesenteric vein thrombus.
Why the study?
Although tumor thrombus is well recognized in solid organ malignancies, its occurrence in malignant lymphoma is rare and may lead to diagnostic challenges.
Case Report (n=1)
No
Malignant lymphoma should be considered in the differential diagnosis for abdominal masses presenting with tumor thrombus, to ensure adequate tissue sampling and appropriate specimen handling for diagnostic immunophenotypic and genetic analyses.
Supports including lymphoma in mesenteric tumor thrombus differentials; hypothesis-generating for intravascular DLBCL involvement.
Intravascular tumor thrombus, also referred to as tumor thrombus, is a well-recognized finding in various solid organ malignancies.Although rare, there have also been several case reports of tumor thrombus in malignant lymphoma.We report a case of diffuse large B-cell lymphoma (DLBCL) presenting as a mesenteric mass with tumor thrombus involving the superior mesenteric vein (SMV).A 76-year-old woman presented with abdominal pain.Contrast-enhanced computed tomography (CT) revealed a well-defined, lobulated mesenteric mass with heterogeneous enhancement.A tumor thrombus extending into the SMV was also identified.Fluorine-18 fluorodeoxyglucose positron emission tomography/CT demonstrated intense fluorodeoxyglucose uptake in both the mesenteric tumor and the SMV tumor thrombus (maximum standardized uptake value = 45.9).Based on these clinical and imaging findings, malignant lymphoma was considered the leading diagnosis.A CT-guided core needle biopsy was performed, and DLBCL was confirmed histopathologically.Although rare, malignant lymphoma can present with tumor thrombus.Failure to consider malignant lymphoma before biopsy may result in inadequate tissue sampling and inappropriate specimen handling, particularly because fresh tissue is required for immunophenotypic and genetic analyses.This may lead to delayed or inaccurate diagnosis.Therefore, malignant lymphoma should not be excluded from the differential diagnosis solely because tumor thrombus is present.
No takes yet. Share an insight, caveat, or question.
Katahira et al. (2026) conducted a case report in Diffuse Large B-cell Lymphoma (DLBCL) (n=1). Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) was evaluated. A 76-year-old woman was diagnosed with diffuse large B-cell lymphoma presenting atypically with a mesenteric mass and a tumor thrombus extending into the superior mesenteric vein.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: